Desktop Genetics, a London, UK-based company developing software for genome editing, raised £1.4m in funding.
Backers included Angels in MedCity, the London Co-Investment Fund, IQ Capital Partners and a consortium of sector expert private investors including Dr Jonathan Milner (Deputy Chairman and Founder of Abcam plc), Dr Martin Murphy (CEO of Syncona Partners LLP) and Dr Darrin M Disley (CEO of Horizon Discovery Group plc).
The company will use the funds to continue to develop the platform and expand operations.
Led by Riley Doyla, CEO, Victor Dillard, CFO, and Edward Perello, CBO, Desktop Genetics is developing software for genome editing that allows scientists to design, build and test the DNA molecules needed to turn genomic information into medical innovation.
Its DESKGEN allows scientists to design any genome-editing experiment in any cell line, and generate tailored CRISPR library designs for their research.